NEW YORK, Oct 6 - PPGx of Morrisville, NC, said Friday that Bristol-Myers Sqibb (NYSE: BMY) has signed on for early access to its GeneTrial software for pharmacogenomics research.

The GeneTrials platform is designed to manage the vast amount of publicly available and in-house clinical and genomic data.